Richard G. Stock, MD

Richard G. Stock, MD

Icahn School of Medicine at Mount Sinai

New York, New York

Dr. Richard Stock has dedicated his career to delivering the highest quality care to patients using the most advanced technology available, including intensity modulated radiation therapy (IMRT), Novalis shaped beam radiosurgery, real-time ultrasound guided prostate seed implants and Mammosite, all of which allows for meticulously targeting the tumor while achieving maximal sparing of normal tissues. Dr. Stock has served on the board of American College of Radiology Testing and the American Brachytherapy Society, where he is member at large, and as guest editor of a special Brachytherapy issue of Techniques in Urology. He has lectured and presented at dozens of meetings and symposiums across the country and internationally, including New York, San Francisco, Chicago, Philadelphia, Boston, Spain, Holland, France and Japan. Dr. Stock completed his internship at Beth Israel Medical Center and his specialty training at Memorial Sloan-Kettering Cancer Center. He is listed in America's Top Doctors.

Articles by Richard G. Stock, MD

Long-Term Outcomes of Permanent Brachytherapy

Richard G. Stock, MD, compares long-term overall survival and morbidity outcomes of brachytherapy alone versus a brachytherapy/ external beam combination in intermediate and high risk prostate cancer. He also discusses factors that could affect those outcomes, such as the patient’s intermediate-risk features, duration of androgen deprivation therapy (ADT), and technique of seed implantation.

Read More
  • 1
  • 2

Join the GRU Community

- Why Join? -